ENCOURVE Trademark

Trademark Overview

On Thursday, January 20, 2011, a trademark application was filed for ENCOURVE with the United States Patent and Trademark Office. The USPTO has given the ENCOURVE trademark a serial number of 85222116. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 1, 2014. This trademark is owned by Glaxo Group Limited. The ENCOURVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
encourve

General Information

Serial Number85222116
Word MarkENCOURVE
Filing DateThursday, January 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word "ENCOURVE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, September 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2014EXTENSION 5 GRANTED
Wednesday, January 22, 2014EXTENSION 5 FILED
Wednesday, January 22, 2014TEAS EXTENSION RECEIVED
Friday, August 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2013EXTENSION 4 GRANTED
Tuesday, July 23, 2013EXTENSION 4 FILED
Thursday, August 22, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 23, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2013EXTENSION 3 GRANTED
Thursday, January 3, 2013EXTENSION 3 FILED
Thursday, January 3, 2013TEAS EXTENSION RECEIVED
Thursday, August 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2012EXTENSION 2 GRANTED
Friday, July 20, 2012EXTENSION 2 FILED
Wednesday, August 8, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 20, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2011PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 14, 2011ASSIGNED TO EXAMINER
Tuesday, January 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

encourve pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological